Ixensor Co Documents
Documents
0
Ticker
6734.TWO
ISIN
TW0006734007
Ixensor Co SEC Filings
Type | Report | Date |
|---|---|---|
| No documents available | ||
Ixensor Co Documents 2026
This page contains all official documents and SEC filings for Ixensor Co stock (6734.TWO, ISIN: TW0006734007). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 0 documents are available. Data is updated regularly to provide investors with a complete overview of Ixensor Co's regulatory filings.
Ixensor Co Stock analysis
Ixensor Co iXensor Co., Ltd. generates revenue through its PixoTest Blood Glucose Monitoring System and ovulation detection system, targeting individuals managing diabetes and reproductive health. The company's technology platform measures biochemical parameters including blood sugar, luteinizing hormone, and cholesterol, providing data for diabetes management services. Its integrated medical device solutions serve customers seeking self-monitoring tools for chronic conditions and fertility tracking. The firm's products are designed for direct consumer use, with the PixoTest system offering blood glucose monitoring and the ovulation detection system supporting female hormone cycle management. These solutions leverage the company's platform to deliver personalized health insights without requiring third-party partnerships. The target segments include patients with diabetes and individuals tracking fertility cycles through biochemical monitoring.